GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09645-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Ashita Gadwal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, 342005, India. Hauptthemen laut MEDLINE: Breast Neoplasms, N-Acetylgalactosaminyltransferases, Drug Resistance, Neoplasm, beta Catenin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Intramural Grant- All India Institute of Medical Sciences Jodhpur.
Abstract (Originalsprache)
BACKGROUND: Altered glycosylation plays a role in carcinogenesis. GALNT14 promotes cancer stem-like properties and drug resistance. GDF-15 is known to induces drug resistance and stemness markers for maintenance of breast cancer (BC) stem-like cell state. Currently there is lack of data on association of GDF-15 and GALNTs. In this study, the expression and interaction of GALNT14 and GDF-15 with stemness (OCT4 and SOX2) and drug resistance (ABCC5) markers were evaluated in BC. METHODS: We investigated tumour tissue from 30 BC patients and adjacent non-tumour tissues. Expression of serum GALNT14 from BC patients and matched healthy controls was evaluated. Expression of GALNT14, GDF-15, OCT4, SOX2, ABCC5, and β-catenin in BC tissue was determined by RT-PCR. Knockdown of GALNT14 and GDF-15 in the MCF-7 cell line was done through siRNA, gene expression and protein expression of β-catenin by western blot were determined. RESULTS: A significant increase in the expression of GALNT14, GDF-15, OCT4, SOX2, ABCC5, and β-catenin was observed in BC tumour tissues compared to adjacent non-tumour tissues. The serum level of GALNT14 was significantly high in BC patients (80.7 ± 65.3 pg/ml) compared to healthy controls (12.2 ± 9.12 pg/ml) (p < 0.000). To further analyse the signalling pathway involved in BC stemness and drug resistance, GALNT14 and GDF-15 were knocked down in the MCF-7 cell line, and it was observed that after knockdown, the expression level of OCT4, SOX2, ABCC5, and β-catenin was decreased, and co-knockdown with GALNT14 and GDF-15 further decreased the expression of genes. CONCLUSION: It can be concluded that GALNT14, in association with GDF-15, promotes stemness and intrinsic drug resistance in BC, possibly through the β-catenin signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, 342005, India.
- Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, 342005, India. dr.purvipurohit@gmail.com.
- Department of Oncosurgery, All India Institute of Medical Sciences, Jodhpur, India.
- Department of Radiation Oncology, All India Institute of Medical Sciences, Jodhpur, India.
- Department of General Surgery, All India Institute of Medical Sciences, Jodhpur, India.
- Department of Pathology, All India Institute of Medical Sciences, Jodhpur, India.
Förderung
- Intramural Grant- All India Institute of Medical Sciences Jodhpur
Zitieren
APA
Gadwal, A., Purohit, P., Khokhar, M., Vishnoi, J. R., Pareek, P., Choudhary, R., Elhence, P., Banerjee, M., & Sharma, P. (2024). GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09645-9
Vancouver
Gadwal A, Purohit P, Khokhar M, Vishnoi JR, Pareek P, Choudhary R, et al. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09645-9
BibTeX
@article{Gadwal2024,
author = {Gadwal, Ashita and Purohit, Purvi and Khokhar, Manoj and Vishnoi, Jeewan Ram and Pareek, Puneet and Choudhary, Ramkaran and Elhence, Poonam and Banerjee, Mithu and Sharma, Praveen},
title = {GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09645-9}
}
EUVIMED